Bleeding from gastrointestinal tract recurrence of non-seminomatous germ cell tumour testis, showing temporary response to gemcitabine and oxaliplatin chemotherapy.
The first reported case of gemcitabine/oxaliplatin (GemOx) chemotherapy used for recurrent non-seminomatous germ cell tumour of the testis metastatic to the gastrointestinal tract causing uncontrolled bleeding which induced a temporary response.
Regional Cancer Treatment Service, Midcentral DHB, Palmerston North Hospital, Palmerston North, New Zealand. steph_prince@hotmail.com.
Stephanie K
SK
Prince
Garry
G
Forgeson
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006471:Gastrointestinal Hemorrhage / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy* / Q000556:secondary; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D009373:Neoplasms, Germ Cell and Embryonal / Q000473:pathology* / Q000556:secondary; D009944:Organoplatinum Compounds / Q000008:administration & dosage*; D000077150:Oxaliplatin; D010166:Palliative Care; D011859:Radiography; D013736:Testicular Neoplasms / Q000473:pathology*; D013792:Thalidomide / Q000008:administration & dosage; D013921:Thrombocytopenia / Q000209:etiology; D000093542:Gemcitabine
D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D003841:Deoxycytidine; D013792:Thalidomide; D000093542:Gemcitabine